Legal Penalties for Selling Hemp-Derived Cannabinoids to Minors in Tennessee
Tennessee hemp-derived cannabinoid penalties now include mandatory jail time and fines for selling to minors. This law aims to protect youth from unregulated psychoactive hemp products. Clinicians should understand these penalties to counsel patients and…
How Cannabis Use May Affect Male Fertility: Expert Insights
Emerging evidence shows cannabis impact on male fertility by disrupting hormone regulation and reducing sperm quality. Clinicians should counsel men of reproductive age about these potential effects. Understanding cannabis impact on male fertility is…
Cannabis, Psychedelics, and the Profit Motive Blocking Psychiatric Drugs
The 2026 cannabis psychedelic research update reveals emerging clinical insights into psychiatric drug development. This update highlights barriers created by profit motives that delay patient access. Clinicians must stay informed about these…
Trump Administration Reclassifies Cannabis: Impact on Medical Research
The federal cannabis reclassification medical research shift could accelerate clinical trials and improve evidence-based prescribing. This policy change removes barriers to studying cannabis's therapeutic potential. Clinicians should monitor emerging…
Federal Judge Weighs Medicare Cannabinoid Reimbursement Decision
A federal judge is reviewing Medicare cannabinoid reimbursement policies that could expand access to hemp-derived cannabis medications. This decision impacts coverage for cannabinoids without FDA approval. Clinicians and patients await clarity on…
How Long-Term Cannabis Use Impacts Executive Function and Brain Structure
This article explores cannabis executive function impact, highlighting structural brain changes linked to chronic use. Long-term cannabis users may face impaired decision-making abilities. These findings emphasize the need for informed clinical…
Amrit Baral: Estimates of Cannabis and Classic Psychedelic Use Among Older U.S. Cancer Survivors
This study provides important estimates of cannabis use among older cancer survivors, highlighting prevalence and clinical relevance. Understanding these patterns helps clinicians assess potential drug interactions and symptom management preferences.…
Understanding President Trump’s Executive Order on Medical Cannabis Rescheduling
The federal medical marijuana rescheduling update under President Trump’s executive order aims to remove barriers to research, prescribing, and insurance coverage. This change would enable standardized treatment guidelines and evidence-based dosing…
President Trump’s Administration Reclassifies State-Licensed Medical Marijuana as Lower-Risk Drug
The state-licensed medical marijuana reclassified as lower-risk drug marks a significant policy shift by the Trump administration. This change may reduce regulatory barriers and expand research opportunities. Clinicians should monitor its impact on…
Study: CBD’s Role in Opioid Use Disorder and Relapse Prevention
CBD opioid use disorder research highlights its potential to reduce heroin-seeking behavior by reversing brain changes linked to relapse. This study suggests CBD may complement existing treatments for opioid addiction. Understanding these neurobiological…